Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Option Care Health Inc (OPCH)

  • SEC News
  • Oct. 30, 2025, 10:56 UTC
  • 4
  • 1 comments

(30% Negative) OPTION CARE HEALTH, INC. (OPCH) Reports Q4 2025 Financial Results

Comment Full text

Cardinal Health Inc (CAH)

  • SEC News
  • Oct. 30, 2025, 10:52 UTC
  • 4
  • 1 comments

(30% Negative) Cardinal Health, Inc. (CAH) Reports Q4 2025 Financial Results

Comment Full text

IX Biopharma LTD. (42C)

  • SEC News
  • Oct. 30, 2025, 10:45 UTC
  • 4
  • 0 comments

Placements: Proposed Placement To Raise Gross Proceeds No Less Than S$5 Million - Receipt of LQN

Comment Full text

Merck & Company Inc (MRK)

  • SEC News
  • Oct. 30, 2025, 10:40 UTC
  • 5
  • 1 comments

(10% Negative) Merck & Co., Inc. (MRK) Reports Q4 2025 Financial Results

Comment Full text

Nuvalent Inc (NUVL)

  • SEC News
  • Oct. 30, 2025, 10:37 UTC
  • 5
  • 1 comments

(10% Negative) NUVALENT, INC. (NUVL) Reports Q4 2025 Financial Results

Comment Full text

Omnicell Inc (OMCL)

  • SEC News
  • Oct. 30, 2025, 10:35 UTC
  • 3
  • 1 comments

(19% Negative) OMNICELL, INC. (OMCL) Reports Q4 2025 Financial Results

Comment Full text

Ekso Bionics Holdings Inc (EKSO)

  • SEC News
  • Oct. 30, 2025, 10:35 UTC
  • 3
  • 1 comments

(10% Negative) Ekso Bionics Holdings, Inc. (EKSO) Announces Business Combination

Comment Full text

Agios Pharmaceuticals Inc (AGIO)

  • SEC News
  • Oct. 30, 2025, 10:32 UTC
  • 4
  • 1 comments

(30% Negative) Agios Pharmaceuticals, Inc. (AGIO) Reports Q4 2025 Financial Results

Comment Full text

Amneal Pharmaceuticals Inc. (AMRX)

  • SEC News
  • Oct. 30, 2025, 10:19 UTC
  • 4
  • 1 comments

(30% Negative) AMNEAL PHARMACEUTICALS, INC. (AMRX) Reports Q4 2025 Financial Results

Comment Full text

Integra LifeSciences Holdings (IART)

  • SEC News
  • Oct. 30, 2025, 10:15 UTC
  • 4
  • 1 comments

(30% Negative) INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Reports Q4 2025 Financial Results

Comment Full text
  • Previous
  • 42
  • 43
  • 44
  • 45
  • 46
  • Next

Search

News categories

  • Technical Exchange News(10321)
  • Event(1442)
  • SEC News(175251)
  • FDA Approval(9644)
  • Company Report(721)
  • Business News(117531)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin